Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Crossref DOI link: https://doi.org/10.1007/s00432-015-1988-0
Published Online: 2015-05-23
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hochhaus, Andreas
Baccarani, Michele
Giles, Francis J.
le Coutre, Philipp D.
Müller, Martin C.
Reiter, Andreas
Santanastasio, Helene
Leung, Mimi
Novick, Steven
Kantarjian, Hagop M.
License valid from 2015-05-23